News
NVYTF
0.501
NaN%
--
Novacyt Updates Liquidity Agreement Activity and Confirms Total Voting Rights
TipRanks · 4d ago
Novacyt launches rights issue to fund SCD deal and bolster balance sheet
TipRanks · 4d ago
Novacyt Completes Acquisition of Southern Cross Diagnostics
TipRanks · 4d ago
Novacyt buys Australian distributor Southern Cross Diagnostics to boost APAC growth
TipRanks · 02/23 07:23
Novacyt Reports January Liquidity Agreement Trades and Confirms Total Voting Rights
TipRanks · 02/02 15:47
Novacyt’s Yourgene Wins Renewal of Major NIPT Contract with St George’s
TipRanks · 01/27 07:18
Novacyt Delivers In-Line 2025 Revenues as New Genomic Instruments Drive Growth
TipRanks · 01/21 07:22
Novacyt Updates Market on December Liquidity Operations and Voting Rights
TipRanks · 01/02 13:32
Novacyt Provides Monthly Update on Liquidity Agreement and Voting Rights
TipRanks · 12/01/2025 12:03
Novacyt Updates on Liquidity Agreement and Voting Rights
TipRanks · 11/03/2025 14:32
Novacyt Unveils Growth Strategy and FY25 Outlook
TipRanks · 10/22/2025 06:20
Novacyt Provides Update on Liquidity Agreement and Voting Rights
TipRanks · 10/01/2025 15:03
Novacyt S.A. Reports Stable Revenue Amid Strategic Growth
TipRanks · 10/01/2025 03:51
Novacyt Reports Steady Growth and Strategic Advancements in H1 2025
TipRanks · 09/30/2025 06:16
Novacyt to Announce Interim Results for H1 2025
TipRanks · 09/18/2025 06:07
Weekly Report: what happened at NVYTF last week (0908-0912)?
Weekly Report · 09/15/2025 10:53
Novacyt Appoints Singer Capital Markets as Joint Corporate Broker
TipRanks · 09/15/2025 06:09
Novacyt Concludes Legal Proceedings with Lab 21 Subsidiary
TipRanks · 09/12/2025 09:02
Weekly Report: what happened at NVYTF last week (0901-0905)?
Weekly Report · 09/08/2025 10:55
More
Webull provides a variety of real-time NVYTF stock news. You can receive the latest news about Novacyt through multiple platforms. This information may help you make smarter investment decisions.
About NVYTF
Novacyt SA is a France-based company providing biotechnological solutions. The Company develops and markets solutions dedicated to the field of liquid-based cytology and molecular biology. It provides diagnostic products used in oncology, microbiology, haematology, and serology testing. The Company develops secure automated cytology named NovaPrep Processor System. It offers a solution of cytological sampling to help in the detection of precancerous and cancerous lesions. It creates bottles specifically dedicated to the optimization of cell collection. The Company’s range of products includes Bottle Gyn and No Gyn Bottle.